Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Organic & Biomolecular Chemistry
|
July 26, 2021
Copper-promoted direct amidation of isoindolinone scaffolds by sodium persulfate
Huifang Lai, Jiexin Xu, Jin Lin, et al.
Physics of Fluids (Woodbury, N.Y. : 1994)
|
July 4, 2017
Selection of internal wave beam directions by a geometric constraint provided by topography
Zhiwu Chen, Jieshuo Xie, Jiexin Xu, et al.
Science Advances
|
February 19, 2025
Accelerated internal tides in a warming climate
Yankun Gong, Zhiwu Chen, Jiexin Xu, et al.
Bioorganic Chemistry
|
May 20, 2025
Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation
Huifang Lai, Yijie Liang, Jiexin Xu, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
February 16, 2024
Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer's disease
Chuanyu Yu, Xueyan Liu, Bingxiang Ma, et al.
European Journal of Medicinal Chemistry
|
January 22, 2023
Novel neuroprotective pyromeconic acid derivatives with concurrent anti-Aβ deposition, anti-inflammatory, and anti-oxidation properties for treatment of Alzheimer's disease
Xueyan Liu, Chuanyu Yu, Yuxing Yao, et al.
Bioorganic Chemistry
|
April 20, 2026
Design, synthesis, and biological evaluation of pyranone-carbamate hybrids as selective butyrylcholinesterase inhibitors with anti-neuroinflammatory activity for Alzheimer's disease
Xueyan Liu, Jiexin Xu, Chen Lin, et al.
Bioorganic Chemistry
|
May 10, 2025
A novel carbamate-based hybrid derivative with anti-neuroinflammatory properties as a selective butyrylcholinesterase inhibitor for Alzheimer's disease therapy
Xueyan Liu, Jiexin Xu, Chuanyu Yu, et al.
Pharmacological Research
|
June 21, 2025
AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy
Xueyan Liu, Jiexin Xu, Shuping Zheng, et al.
Life Sciences
|
October 3, 2024
Compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one downregulation of Galectin-3 ameliorates Aβ pathogenesis-induced neuroinflammation in 5 × FAD mice
Xueyan Liu, Ping Chen, Wei Wu, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Organic & Biomolecular Chemistry
|
July 26, 2021
Copper-promoted direct amidation of isoindolinone scaffolds by sodium persulfate
Huifang Lai, Jiexin Xu, Jin Lin, et al.
Physics of Fluids (Woodbury, N.Y. : 1994)
|
July 4, 2017
Selection of internal wave beam directions by a geometric constraint provided by topography
Zhiwu Chen, Jieshuo Xie, Jiexin Xu, et al.
Science Advances
|
February 19, 2025
Accelerated internal tides in a warming climate
Yankun Gong, Zhiwu Chen, Jiexin Xu, et al.
Bioorganic Chemistry
|
May 20, 2025
Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation
Huifang Lai, Yijie Liang, Jiexin Xu, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
February 16, 2024
Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer's disease
Chuanyu Yu, Xueyan Liu, Bingxiang Ma, et al.
European Journal of Medicinal Chemistry
|
January 22, 2023
Novel neuroprotective pyromeconic acid derivatives with concurrent anti-Aβ deposition, anti-inflammatory, and anti-oxidation properties for treatment of Alzheimer's disease
Xueyan Liu, Chuanyu Yu, Yuxing Yao, et al.
Bioorganic Chemistry
|
April 20, 2026
Design, synthesis, and biological evaluation of pyranone-carbamate hybrids as selective butyrylcholinesterase inhibitors with anti-neuroinflammatory activity for Alzheimer's disease
Xueyan Liu, Jiexin Xu, Chen Lin, et al.
Bioorganic Chemistry
|
May 10, 2025
A novel carbamate-based hybrid derivative with anti-neuroinflammatory properties as a selective butyrylcholinesterase inhibitor for Alzheimer's disease therapy
Xueyan Liu, Jiexin Xu, Chuanyu Yu, et al.
Pharmacological Research
|
June 21, 2025
AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy
Xueyan Liu, Jiexin Xu, Shuping Zheng, et al.
Life Sciences
|
October 3, 2024
Compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one downregulation of Galectin-3 ameliorates Aβ pathogenesis-induced neuroinflammation in 5 × FAD mice
Xueyan Liu, Ping Chen, Wei Wu, et al.
Page
of 1